Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Sep 6:7:392.
doi: 10.3389/fcimb.2017.00392. eCollection 2017.

Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ruixue Huang  1 , Huacheng Ning  1 , Minxue Shen  2   3 , Jie Li  2   3 , Jianglin Zhang  2   3 , Xiang Chen  2   3
Affiliations
Meta-Analysis

Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ruixue Huang et al. Front Cell Infect Microbiol. .

Abstract

Objective: Atopic dermatitis (AD) is a prevalent, burdensome, and psychologically important pediatric concern. Probiotics have been suggested as a treatment for AD. Some reports have explored this topic; however, the utility of probiotics for AD remains to be firmly established. Methods: To assess the effects of probiotics on AD in children, the PubMed/Medline, Cochrane Library Scopus, and OVID databases were searched for reports published in the English language. Results: Thirteen studies were identified. Significantly higher SCORAD values favoring probiotics over controls were observed (mean difference [MD], -3.07; 95% confidence interval [CI], -6.12 to -0.03; P < 0.001). The reported efficacy of probiotics in children < 1 year old was -1.03 (95%CI, -7.05 to 4.99) and that in children 1-18 years old was -4.50 (95%CI, -7.45 to -1.54; P < 0.001). Subgroup analyses showed that in Europe, SCORAD revealed no effect of probiotics, whereas significantly lower SCORAD values were reported in Asia (MD, -5.39; 95%CI, -8.91 to -1.87). Lactobacillus rhamnosus GG (MD, 3.29; 95%CI, -0.30 to 6.88; P = 0.07) and Lactobacillus plantarum (MD, -0.70; 95%CI, -2.30 to 0.90; P = 0.39) showed no significant effect on SCORAD values in children with AD. However, Lactobacillus fermentum (MD, -11.42; 95%CI, -13.81 to -9.04), Lactobacillus salivarius (MD, -7.21; 95%CI, -9.63 to -4.78), and a mixture of different strains (MD, -3.52; 95%CI, -5.61 to -1.44) showed significant effects on SCORAD values in children with AD. Conclusions: Our meta-analysis indicated that the research to date has not robustly shown that probiotics are beneficial for children with AD. However, caution is needed when generalizing our results, as the populations evaluated were heterogeneous. Randomized controlled trials with larger samples and greater power are necessary to identify the species, dose, and treatment duration of probiotics that are most efficacious for treating AD in children.

Keywords: children; constipation; meta-analysis; probiotics; randomized controlled trial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flow diagram of articles included in the meta-analysis.
Figure 2
Figure 2
(A) Risk of bias graph, with each risk of bias item presented as a percentage across all included studies. (B) Risk of bias summary, with each risk of bias item for each included study.
Figure 3
Figure 3
MD scoring with probiotics treatment compared to control and placebo interventions. 95%CI, 95% confidence interval.
Figure 4
Figure 4
MD scoring with probiotics treatment compared to control and placebo interventions by age group.
Figure 5
Figure 5
MD scoring with probiotics treatment compared to control and placebo interventions by location.
Figure 6
Figure 6
MD scoring with probiotics treatment compared to control and placebo interventions by cultured organisms.
Figure 7
Figure 7
Funnel plot: SD by mean difference and each dot represents 1 RCT.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. (1993). Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186, 23–31. 10.1159/000247298 - DOI - PubMed
    1. Alexander P. E., Bonner A. J., Agarwal A., Li S. A., Hariharan A. T., Izhar Z., et al. . (2016). Sensitivity subgroup analysis based on single-center vs. multi-center trial status when interpreting meta-analyses pooled estimates: the logical way forward. J. Clin. Epidemiol. 74, 80–92. 10.1016/j.jclinepi.2015.08.027 - DOI - PubMed
    1. Brouwer M. L., Wolt-Plompen S. A., Dubois A. E., van der Heide S., Jansen D. F., Hoijer M. A., et al. . (2006). No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin. Exp. Allergy. 36, 899–906. 10.1111/j.1365-2222.2006.02513.x - DOI - PubMed
    1. Chamlin S. L., Chren M. M. (2010). Quality-of-life outcomes and measurement in childhood atopic dermatitis. Immunol. Allergy Clin. North Am. 30, 281–288. 10.1016/j.iac.2010.05.004 - DOI - PMC - PubMed
    1. Chang H. Y., Chen J. H., Chang J. H., Lin H. C., Lin C. Y., Peng C. C. (2017). Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis. PLoS ONE 12:e171579. 10.1371/journal.pone.0171579 - DOI - PMC - PubMed